Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12538599 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
Conditions: Osteoporosis;   Humoral Hypercalcemia of Malignancy;   Hyperparathyroidism
Intervention: Drug: PTHrP (1-36)

Indicates status has not been verified in more than two years